Treace Medical Concepts
TMCI
134 hedge funds and large institutions have $230M invested in Treace Medical Concepts in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 21 closing their positions.
33% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 21
5% more funds holding
Funds holding: 128 → 134 (+6)
0.36% less ownership
Funds ownership: 64.09% → 63.72% (-0.36%)
7% less call options, than puts
Call options by funds: $2.56M | Put options by funds: $2.74M
13% less capital invested
Capital invested by funds: $264M → $230M (-$34.5M)
28% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 50
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$8.26M |
| 2 |
JP Morgan Chase
New York
|
+$5.53M |
| 3 |
AC
Armistice Capital
New York
|
+$5.37M |
| 4 |
GA
Gagnon Advisors
New York
|
+$3.15M |
| 5 |
Morgan Stanley
New York
|
+$2.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.49M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$8.28M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.67M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.71M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.41M |
TMCI Hedge Fund Activity: Q3 2024 in Review
134 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2024, worth a combined $230M — down 13% from $264M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new TMCI positions and 21 closed out — a net gain of 7 holders — while 36 added to existing stakes and 50 trimmed.
The largest buyer was Gagnon Securities, adding an estimated $8.26M. The largest seller was Soleus Capital Management, cutting an estimated $9.49M.
- 134 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2024, up from 128 in Q2 2024.
- Funds reported $230M of Treace Medical Concepts stock for Q3 2024, down 13% quarter-over-quarter.
- 28 funds opened new Treace Medical Concepts positions in Q3 2024 and 21 closed out, a net change of +7 holders.
- The largest Treace Medical Concepts buyer in Q3 2024 was Gagnon Securities, an estimated $8.26M added.
- The largest Treace Medical Concepts seller in Q3 2024 was Soleus Capital Management, an estimated $9.49M sold.
Based on aggregated 13F filings for Q3 2024.